8-K: Green Thumb Industries Reports 4% Revenue Increase in Third Quarter 2024, Achieves $89 Million Adjusted EBITDA
Quarterly Report
Green Thumb Industries announced a 4% year-over-year revenue increase to $287 million for the third quarter of 2024, alongside an adjusted EBITDA of $89 million.
Summary
- Green Thumb Industries reported a revenue of $287 million for the third quarter of 2024, a 4% increase compared to the same period last year.
- The company's GAAP net income for the quarter was $9 million, or $0.04 per basic and diluted share.
- Adjusted EBITDA for the third quarter reached $89 million, representing 31% of revenue.
- Green Thumb generated $152 million in cash flow from operations over the nine months, after paying $88 million in taxes.
- The company opened four new RISE Dispensaries during the quarter, three in Florida and one in New York.
- A new $150 million 5-year credit facility was secured at an interest rate of SOFR +5.00%.
- Green Thumb retired $225 million of senior secured debt due in 2025.
- The company authorized a $50 million share repurchase program from September 23, 2024, to September 22, 2025.
Sentiment
Score: 7
Explanation: The sentiment is positive due to solid revenue growth, strong adjusted EBITDA, and successful debt refinancing. However, some concerns exist regarding decreased comparable sales and increased expenses.
Positives
- Revenue increased by 4% year-over-year to $287 million.
- The company achieved a solid adjusted EBITDA of $89 million, representing 31% of revenue.
- Green Thumb secured a new $150 million credit facility with favorable terms.
- The retirement of $225 million in senior secured debt strengthens the balance sheet.
- The company generated $152 million in cash flow from operations over nine months.
- Four new dispensaries were opened, expanding the company's retail footprint.
- The share repurchase program indicates management's confidence in the company's value.
Negatives
- Comparable sales decreased by 2.7% in stores open at least 12 months.
- Net income decreased to $8.6 million from $10.5 million in the prior year period.
- Total selling, general, and administrative expenses increased to $105 million, or 36.6% of revenue.
- EBITDA decreased to $71.1 million from $74.7 million in the comparable period.
Risks
- The cannabis industry remains subject to regulatory uncertainty and potential changes in federal and state laws.
- The company faces intense competition in the cannabis market.
- Price compression in certain markets could impact revenue and profitability.
- The company is exposed to risks related to litigation and ongoing claims.
- The company's reliance on third-party software providers could pose operational risks.
- The company faces risks related to product liability and potential recalls.
Future Outlook
The company is confident that its focus on operational excellence, superior product quality, and brands that resonate with consumers will drive future success. They plan to double down on building brands that Americans want and love.
Management Comments
- Ben Kovler stated that the team delivered impressive results, including $287 million in revenue and $89 million in Adjusted EBITDA.
- Ben Kovler highlighted the achievement of securing a five-year, $150 million syndicated bank loan facility.
- Anthony Georgiadis expressed pride in the team's performance and noted market share gains across the Consumer Packaged Goods brand portfolio.
- Anthony Georgiadis stated that the company is confident in its focus on operational excellence and product quality for future success.
Industry Context
The results reflect the ongoing growth and challenges within the cannabis industry, including increasing competition and price compression. Green Thumb's expansion and financial performance are being closely watched by investors in the sector.
Comparison to Industry Standards
- Green Thumb's 4% revenue growth is moderate compared to some high-growth cannabis companies, but it is a solid result given the current market conditions.
- The adjusted EBITDA margin of 31% is competitive within the industry, indicating strong operational efficiency.
- The successful refinancing of debt and securing a new credit facility at SOFR +5.00% is a positive sign of financial health and stability, which is better than many of its peers.
- The company's expansion with four new dispensaries is in line with the growth strategies of other multi-state operators (MSOs) in the cannabis sector.
- Compared to companies like Curaleaf and Trulieve, Green Thumb's revenue growth is more modest, but its focus on profitability and cash flow is a differentiating factor.
Stakeholder Impact
- Shareholders will benefit from the share repurchase program and the company's focus on profitability.
- Employees may see increased opportunities as the company expands.
- Customers will have access to more retail locations and a wider range of products.
- Creditors will benefit from the company's improved financial stability.
Next Steps
- The company plans to focus on building brands that resonate with consumers.
- Green Thumb will continue to focus on operational excellence and product quality.
- The company will continue to execute its growth strategy.
- The company will host a conference call on November 7, 2024, to discuss the results.
Key Dates
| Date | Description |
|---|---|
| September 10, 2024 | The company's previous share repurchase program expired. |
| September 13, 2024 | The Board of Directors authorized a new share repurchase program. |
| September 23, 2024 | The new share repurchase program commenced. |
| September 30, 2024 | End of the third quarter for which financial results are reported. |
| September 22, 2025 | The share repurchase program is set to expire. |
| April 30, 2025 | Maturity date of the retired senior secured debt. |
| November 7, 2024 | Date of the earnings release and conference call. |
Keywords
cannabis, dispensaries, revenue, EBITDA, retail, consumer packaged goods, debt, share repurchase, credit facility, financial results
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.